Medical Surveillance Monthly Report (MSMR). Volume 3, Number 8, November 1997
Abstract
Prior to the availability and routine use of vaccines against them, adenovirus serotypes 4 and 7 caused recurrent large outbreaks among military basic trainees. Recently, the sole manufacturer of adenovirus vaccines discontinued their production. In order to extend the availability of remaining vaccine stocks, the military services limited their routine use to the relatively high risk fall and winter seasons. In May 1997, the Preventive Medicine staffs at Forts Jackson and Gordon added virus isolation (supported by the Virology Laboratory, Eisenhower Army Medical Center) to their standard acute respiratory disease (ARD) surveillance efforts. In October 1997, the MSMR reported that, through the summer and fall, ARD rates and isolates of adenovirus type 4 from ARD cases persistently rose among basic trainees at Fort Jackson. In addition, adenovirus type 4 isolates were recovered from ARD cases among advanced individual training (AIT) students at Fort Gordon particularly those who had recently completed basic training at Fort Jackson. This report provides detailed information regarding the ARD and adenovirus type 4 experiences at Fort Jackson and Fort Gordon following the discontinuation of routine adenovirus immunization last spring.
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 1997
- Accession Number
- ADA497189
Entities
People
- John Brundage
- Kimmie Kohlhase
- Lisa Pearse
- Mark V Rubertone
Organizations
- Armed Forces Health Surveillance Center